Abstract
The present study evaluates freeze thaw as a simple approach for screening the most appropriate cryoprotectant. Freeze–thaw study is based on the principle that an excipient, which protects nanoparticles during the first step of freezing, is likely to be an effective cryoprotectant. Nanoparticles of rifampicin with high entrapment efficiency were prepared by the emulsion-solvent diffusion method using dioctyl sodium sulfosuccinate (AOT) as complexing agent and Gantrez AN-119 as polymer. Freeze–thaw study was carried out using trehalose and fructose as cryoprotectants. The concentration of cryoprotectant, concentration of nanoparticles in the dispersion, and the freezing temperature were varied during the freeze–thaw study. Cryoprotection increased with increase in cryoprotectant concentration. Further, trehalose was superior to fructose at equivalent concentrations and moreover permitted use of more concentrated nanosuspensions for freeze drying. Freezing temperature did not influence the freeze–thaw study. Freeze-dried nanoparticles revealed good redispersibility with a size increase that correlated well with the freeze–thaw study at 20% w/v trehalose and fructose. Transmission electron microscopy revealed round particles with a size ∼400 nm, which correlated with photon correlation spectroscopic measurements. Differential scanning calorimetry and X-ray diffraction suggested amorphization of rifampicin. Fourier transfer infrared spectroscopy could not confirm interaction of drug with AOT. Nanoparticles exhibited sustained release of rifampicin, which followed diffusion kinetics. Nanoparticles of rifampicin were found to be stable for 12 months. The good correlation between freeze thaw and freeze drying suggests freeze–thaw study as a simple and quick approach for screening optimal cryoprotectant for freeze drying.
Similar content being viewed by others
References
Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J Anat. 1996;189:503–5.
McClean S, Prosser E, Meehan E, O'Malley D, Clarke N, Ramtoola Z, et al. Binding and uptake of biodegradable polydl-lactide micro- and nanoparticles in intestinal epithelia. Eur J Pharm Sci. 1998;6:153–63.
Rodriguez GS, Allémann E, Fessi H, Doelker E. Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res. 2004;21:1428–39.
Oppenheim R. Solid colloidal drug delivery systems: nanoparticles. Int J Pharm. 1981;8:217–34.
Alonso MJ. Nanoparticulate drug carrier technology. In: Cohen S, Bernstein H, editors. Microparticulate systems for the delivery of proteins and vaccines. New York: Marcel Dekker; 1996. p. 203–42. Book chapter.
Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev. 2002;54:631–51.
Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58:1688–713.
Storm G, Belliot SO, Daemen T, Lasic D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev. 1995;17:31–48.
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55:329–47.
Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res. 1997;14:1568–73.
Jaeghere DF, Allemann E, Leroux JC, Stevels W, Feijen J, Doelker E, et al. Formulation and lyoprotection of poly (lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res. 1999;16:859–66.
Saez A, Guzma’n M, Molpeceres J, Aberturas MR. Freeze drying of polycaprolactone and poly(D, L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur J Pharm Biopharm. 2000;50:379–87.
Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(D, L lactide-glycolide) carriers. Eur J Pharm Sci. 1999;8:99–107.
Bozdag S, Dillen K, Vandervoort J, Ludwig A. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D, L-lactide-glycolide) nanoparticles. J Pharm Pharmacol. 2005;57:699–707.
Crowe LM, Reid DS, Crowe JH. Is trehalose special for preserving dry materials? Biophys J. 1996;71:2087–93.
Engel A, Bendas G, Wilhelm F, Mannova M, Ausborn M, Nuhn P. Freeze-drying of liposomes with free and membrane-bound cryoprotectives-the background of protection and damaging process. Int J Pharm. 1994;107:99–110.
Tanaka K, Takeda T, Fuji K, Miyajima K. Cryoprotective mechanism of saccharides on freeze-drying of liposome. Chem Pharm Bull. 1992;40:1–5.
Schwarz C, Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm. 1997;157:171–9.
Shahgaldian P, Gualbert J, Aıssa K, Coleman AW. A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur J Pharm Biopharm. 2003;55:181–4.
Cavalli R, Caputo O, Carlotti ME, Trotta M, Scarnecchia C, Gasco MR. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int J Pharm. 1997;148:47–54.
Zhang L, Liu L, Qian Y, Chen Y. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). Eur J Pharm Biopharm. 2008;69:750–9.
Talsma H, Steenbergen MJV, Salemink PJM, Crommelin DJA. The cryopreservation of liposomes: a differential scanning calorimetry study of the thermal behavior of a liposome dispersion containing mannitol during freezing/thawing. Pharm Res. 1991;8:1021–6.
Chasteigner SD, Cave G, Fessi H, Devissaguet JP, Puisieux F. Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study. Drug Dev Res. 1996;38:116–24.
Kristl J, AlleÂmann E, Gurny R. Formulation and evaluation of zinc phthalocyanine-loaded poly(dl-lactic acid) nanoparticles. Acta Pharm. 1996;46:1–12.
Roy D, Guillon X, Lescure F, Couvreur P, Bru P, Breton P. On shelf stability of freeze-dried poly(methylidene malonate, 2.1.2) nanoparticles. Int J Pharm. 1997;148:165–75.
Guerrero DQ, Quintanar GA, AlleÂmann E, Fessi H, Doelker E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(d, l-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J Microencapsul. 1998;15:107–19.
Franks F. Freeze-drying of bioproducts: putting principles into practice. Eur J Pharm Biopharm. 1998;45:221–9.
Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63:87–94.
Li Y, Wong HL, Shuhendler AJ, Rauth AM, Wu XY. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer–lipid hybrid nanoparticles. J Control Release. 2008;128:60–70.
Muttil P, Kaur J, Kumar K, Yadav AB, Sharma R, Misra A. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci. 2007;32:140–50.
Thakkar VT, Shah PA, Soni TG, Parmar MY, Gohel MC, Gandhi TR. Goodness-of-fit model-dependent approach for release kinetics of levofloxacin hemihydrates floating tablet. Dissolution Technologies. 2009;16:35–9.
Shivakumar HN, Patel PB, Desai BG, Purnima A, Arulmozhi S. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Acta Pharm. 2007;57:269–85.
Shoaib MH, Tazeen J, Merchant HA, Yousuf RI. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak J Pharm Sci. 2006;19:119–24.
Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze drying of poly(epsiloncaprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm. 2006;17:178–88.
Abdelwahed W, Degobert G, Fessi H. Freeze-drying of nanocapsules: impact of annealing on the drying process. Int J Pharm. 2006;324:74–82.
Allison SD, Molina MDC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta. 2000;1468:127–38.
Kuleshova LL, MacFarlane DR, Trounson AO, Shaw JM. Sugars exert a major influence on the vitrification properties of ethylene glycol-based solutions and have low toxicity to embryos and oocytes. Cryobiology. 1999;38:119–30.
Sugrue S. Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements. Am Lab. 1992;24:64–71.
Ahsan F, Rivas IP, Khan MA, Suarez AIT. Targeting to macrophages: role of physicochemical properties of particulate carriers—liposomes and microspheres—on the phagocytosis by macrophages. J Control Release. 2002;79:29–40.
Acknowledgments
The authors wish to acknowledge the Department of Biotechnology (DBT), Government of India, for the grant, and senior research fellowship to Praveen Date, and IIT-B, Mumbai for the TEM study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Date, P.V., Samad, A. & Devarajan, P.V. Freeze Thaw: A Simple Approach for Prediction of Optimal Cryoprotectant for Freeze Drying. AAPS PharmSciTech 11, 304–313 (2010). https://doi.org/10.1208/s12249-010-9382-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9382-3